Pharma Journalist -

Roche announced that the European Commission (EC) approved Vabysmo (faricimab) for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…
Read More...

SAE Media Group: Blake Green, Director Regulatory Affairs, Amgen and Anne Whalen, Previous Director, Novartis invite experts to join for the Medical Devices & IVD Conference SAE…
Read More...

Recommendation based on TACKLE Phase III treatment data showing reduced risk of severe COVID-19 or death AstraZeneca's Evusheld (tixagevimab and cilgavimab, formerly…
Read More...

bluebird bio, Inc. announced the U.S. Food and Drug Administration (FDA) has granted Accelerated Approval of SKYSONA (elivaldogene autotemcel), also known as eli-cel, to slow the…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved the fixed-dose combination of Opdualag (nivolumab and relatlimab) for the first-line treatment of advanced…
Read More...

NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co., Ltd. announced that they have entered into a conditional exclusive license agreement for NeuroBo to develop and commercialize DA-1241…
Read More...

Caladrius Biosciences, Inc. and Cend Therapeutics, Inc. announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September…
Read More...

Gilead Sciences, Inc. announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline, which now conditionally recommends Veklury (remdesivir) for…
Read More...

SAE Media Group reports: The Biosensors for Medical Wearables Conference will welcome Pfizer, AstraZeneca, DiMe, MedRhythms and many more biotech companies Join SAE Media Group at…
Read More...

Avicanna Inc., a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it…
Read More...